Houssem Benlalam

772 total citations
20 papers, 600 citations indexed

About

Houssem Benlalam is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Houssem Benlalam has authored 20 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Houssem Benlalam's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (6 papers). Houssem Benlalam is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (6 papers). Houssem Benlalam collaborates with scholars based in France, Tunisia and Mali. Houssem Benlalam's co-authors include Salem Chouaı̈b, Nathalie Labarrière, Francine Jotereau, Muhammad Zaeem Noman, Boris Linard, Elisabeth Viles, Fathia Mami‐Chouaib, Claudine Kiéda, Meriem Hasmim and Curzio Rüegg and has published in prestigious journals such as The Journal of Immunology, Cancer Research and European Journal of Immunology.

In The Last Decade

Houssem Benlalam

20 papers receiving 596 citations

Peers

Countries citing papers authored by Houssem Benlalam

Since Specialization

Citations

This map shows the geographic impact of Houssem Benlalam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houssem Benlalam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houssem Benlalam more than expected).

Fields of papers citing papers by Houssem Benlalam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houssem Benlalam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houssem Benlalam. The network helps show where Houssem Benlalam may publish in the future.

Co-authorship network of co-authors of Houssem Benlalam

This figure shows the co-authorship network connecting the top 25 collaborators of Houssem Benlalam. A scholar is included among the top collaborators of Houssem Benlalam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houssem Benlalam. Houssem Benlalam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells 2021 ·Vaccines ·(unknown), Alexandre Walencik, Karine Laulagnier, Jean‐Paul Molens, Houssem Benlalam, Brigitte Dréno, Pierre G. Coulie, Martin Pulé, Laurence Chaperot, Joël Plumas	6
2	Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma 2019 ·Cellular Immunology ·M. Samimi, Houssem Benlalam, (unknown), Pauline Gaboriaud, Delphine Fradin, Thibault Kervarrec, (unknown), Virginie Vignard, Astrid Blom, Antoine Touzé, Nadine Gervois, Nathalie Labarrière	14
3	Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity 2018 ·Cancer Immunology Immunotherapy ·(unknown), Thibault Kervarrec, M. Samimi, Houssem Benlalam, (unknown), Régine Vivien, Antoine Touzé, Nathalie Labarrière, Henri Vié, Béatrice Clemenceau	8
4	Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib 2017 ·Cancer Immunology Research ·(unknown), Marina Colombo, (unknown), Meriem Messaoudene, Sylvie Rusakiewicz, Laurence Zitvogel, Éric Vivier, Frédéric Vely, Florence Faure, Brigitte Dréno, Houssem Benlalam, Fanny Bouquet, Ariel Savina, Éric Pasmant, Antoine Toubert, Marie‐Françoise Avril, Anne Caignard	18
5	CD40L confers helper functions to human intra-melanoma class-I-restricted CD4⁺CD8⁺double positive T cells 2016 ·OncoImmunology ·Tiphaine Parrot, Romain Oger, Houssem Benlalam, (unknown), Nicolas Jouand, (unknown), Laurence Preisser, Amir Khammari, Brigitte Dréno, Philippe Guardiola, Yves Delneste, Nathalie Labarrière, Nadine Gervois	11
6	IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4⁺CD8⁺ double‐positive T cells 2016 ·European Journal of Immunology ·Tiphaine Parrot, Mathilde Allard, Romain Oger, Houssem Benlalam, (unknown), (unknown), Laurence Preisser, (unknown), Amir Khammari, Brigitte Dréno, Nathalie Labarrière, Yves Delneste, Philippe Guardiola, Nadine Gervois	27
7	Soluble HLA-I/Peptide Monomers Mediate Antigen-Specific CD8 T Cell Activation through Passive Peptide Exchange with Cell-Bound HLA-I Molecules 2014 ·The Journal of Immunology ·Mathilde Allard, Romain Oger, Houssem Benlalam, (unknown), Klára Echasserieau, Karine Bernardeau, Nathalie Labarrière, François Lang, Nadine Gervois	15
8	Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8+ T lymphocyte emergence 2013 ·Journal of Molecular Medicine ·Houssem Benlalam, (unknown), Abdelali Jalil, (unknown), Bernard Caillou, Philippe Vielh, Andrés Tittarelli, Caroline Robert, Salem Chouaı̈b	9
9	Cytotoxic T cells – Stroma interactions 2011 ·Bulletin du Cancer ·Muhammad Zaeem Noman, Houssem Benlalam, Meriem Hasmim, Salem Chouaı̈b	5
10	Hypoxia-Dependent Inhibition of Tumor Cell Susceptibility to CTL-Mediated Lysis Involves NANOG Induction in Target Cells 2011 ·The Journal of Immunology ·Meriem Hasmim, Muhammad Zaeem Noman, Jessica Lauriol, Houssem Benlalam, Aude Mallavialle, Filippo Rosselli, Fathia Mami‐Chouaib, Catherine Alcaïde‐Loridan, Salem Chouaı̈b	47
11	Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells 2010 ·Critical Reviews in Immunology ·Salem Chouaı̈b, Claudine Kiéda, Houssem Benlalam, Muhammad Zaeem Noman, Fathia Mami‐Chouaib, Curzio Rüegg	75
12	The anti-angiogenic activity of IL-12 is increased in iNOS−/− mice and involves NK cells 2010 ·Journal of Molecular Medicine ·Aleksandra Bielawska‐Pohl, Séverine Blesson, Houssem Benlalam, Aurélie Trenado, Paule Opolon, Olivia Bawa, Valérie Rouffiac, Danuta Duś, Claudine Kiéda, Salem Chouaı̈b	17
13	Gap Junction Communication between Autologous Endothelial and Tumor Cells Induce Cross-Recognition and Elimination by Specific CTL 2009 ·The Journal of Immunology ·Houssem Benlalam, Abdelali Jalil, Meriem Hasmim, Baoxu Pang, Ryad Tamouza, (unknown), Yann Godet, (unknown), Caroline Robert, (unknown), Jacques Neefjes, Thomas Tursz, Fathia Mami‐Chouaib, Claudine Kiéda, (unknown)	25
14	Immune surveillance of human cancer: if the cytotoxic T‐lymphocytes play the music, does the tumoral system call the tune? 2009 ·Tissue Antigens ·Ahmed Hamaï, Houssem Benlalam, Franck Meslin, Meriem Hasmim, (unknown), Intissar Akalay, Bassam Janji, Guy Berchem, Muhammad Zaeem Noman, Salem Chouaı̈b	56
15	ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway 2008 ·Cancer Research ·Ahmed Hamaï, Franck Meslin, Houssem Benlalam, Abdelali Jalil, Maryam Mehrpour, Florence Faure, Yann Lécluse, (unknown), Marie‐Françoise Avril, Caroline Robert, Salem Chouaı̈b	61
16	Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients 2006 ·Cancer Immunology Immunotherapy ·Houssem Benlalam, Virginie Vignard, Amir Khammari, (unknown), Yann Godet, Marie‐Christine Pandolfino, Francine Jotereau, Brigitte Dréno, Nathalie Labarrière	33
17	Immunothérapie du cancer : espoirs et réalités 2006 ·médecine/sciences ·Salem Chouaı̈b, Faten El Hage, Houssem Benlalam, Fathia Mami‐Chouaib	8
18	Identification of Five New HLA-B3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes 2003 ·The Journal of Immunology* ·Houssem Benlalam, Boris Linard, (unknown), Agnès Moreau‐Aubry, Laurent Derré, Elisabeth Viles, Brigitte Dréno, Francine Jotereau, Nathalie Labarrière	44
19	A ras- Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion 2002 ·The Journal of Immunology ·Boris Linard, Stéphane Bezieau, Houssem Benlalam, Nathalie Labarrière, Yannick Guilloux, Elisabeth Viles, Francine Jotereau	64
20	Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy 2001 ·European Journal of Immunology ·Houssem Benlalam, Nathalie Labarrière, Boris Linard, Laurent Derré, Elisabeth Viles, Marie‐Christine Pandolfino, (unknown), Francine Jotereau	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact